» Articles » PMID: 37573289

Circadian Oscillations of Minimal Erythema Dose (MED) Are Also Influenced by Diet in Patients with Psoriasis: A Chronomedical Study

Abstract

Introduction: Minimal erythema dose (MED) remains a parameter of paramount importance to orient narrow-band (NB)-UVB phototherapy in psoriatic (PsO) patients. Recently, circadian rhythm and diet were recognized as potential MED modulators, but their mutual interaction remains understudied. Thus, we aimed to evaluate the potential diet modulation of MED circadian oscillations.

Methods: In the first phase, a cohort study was performed comparing potential MED oscillations (morning, afternoon, and evening) among omnivorous psoriatic patients before and after a phototherapy cycle and omnivorous healthy controls. The two groups were age-, gender-, skin-type-, MED-, and diet-matched. Then, in the second phase, another cohort study was carried out comparing MED oscillations 24 h after the last phototherapeutic session only in psoriatic patients cleared with NB-UVB and undergoing different diets (vegan, vegetarian, paleo , ketogenic, intermittent circadian fasting, and omnivore). Patients with different diets were age-, gender-, and skin-type matched.

Results: In the first phase, we enrolled only omnivores, specifically 54 PsO patients and 54 healthy individuals. Their MED before and after NB-UVB therapy changed significantly among the three different time-points (morning, afternoon, and evening) (p < 0.001). The time effect was statistically significant in both groups before and after phototherapy. In the second phase, we enrolled 144 PsO patients (vegan, vegetarian, paleo, ketogenic, intermittent circadian fasting, and omnivore). MED circadian oscillations preserved a significant difference also after clearance and were influenced by diet type and time of day (p < 0.001). In particular, vegans displayed the lowest MED values, whilst Ramadan fasting showed the highest values in morning, afternoon, and evening.

Conclusions: Diet, like other ongoing therapies, should be reported in the medical records of patients with psoriasis undergoing NB-UVB and patients with lower MEDs should be preferentially treated in the morning when the MED is higher.

Citing Articles

Atorvastatin attenuates the expression of damage-associated molecular patterns and inflammatory cytokines in patients with psoriasis.

Armyra K, Ektesabi A, Tsoporis J, Izhar S, Triantafyllis A, Leong-Poi H Pharmacol Rep. 2025; .

PMID: 40085417 DOI: 10.1007/s43440-025-00710-z.


The role of bilirubin as a biomarker of rheumatic diseases: a systematic review and meta-analysis.

Zinellu A, Mangoni A Front Immunol. 2024; 15:1369284.

PMID: 38947324 PMC: 11211262. DOI: 10.3389/fimmu.2024.1369284.


Anti-Interleukin 17A Biologic Therapy Attempts on Livedoid Vasculopathy: A Report of Case Series.

Qi F, Gao Y, Jin H Clin Cosmet Investig Dermatol. 2024; 17:1043-1048.

PMID: 38742169 PMC: 11090123. DOI: 10.2147/CCID.S455903.


Assessing causal relationships between gut microbiota and psoriasis: evidence from two sample Mendelian randomization analysis.

Li Y, Chen G, Hu X, Bao Y, Wu C, Zeng N Sci Rep. 2024; 14(1):8831.

PMID: 38632320 PMC: 11024213. DOI: 10.1038/s41598-024-59603-5.


Sociodemographic and Environmental Determinants of Regional Prevalence of Psoriasis in Germany: A Spatiotemporal Study of Ambulatory Claims Data.

Andrees V, Wolf S, Sander M, Augustin M, Augustin J Acta Derm Venereol. 2024; 104:adv12430.

PMID: 38323497 PMC: 10863622. DOI: 10.2340/actadv.v104.12430.


References
1.
Damiani G, Poli P, Pacifico A, Rosi E, Allocca G, Berti E . The Relevant Oral Burden of Patients with Hidradenitis Suppurativa. Dermatol Ther (Heidelb). 2023; 13(10):2319-2329. PMC: 10539249. DOI: 10.1007/s13555-023-01006-x. View

2.
Damiani G, Franchi C, Pigatto P, Altomare A, Pacifico A, Petrou S . Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents. World J Hepatol. 2018; 10(2):329-336. PMC: 5838451. DOI: 10.4254/wjh.v10.i2.329. View

3.
Yen H, Chi C . Is psoriasis associated with dementia or cognitive impairment? A Critically Appraised Topic. Br J Dermatol. 2020; 184(1):34-42. DOI: 10.1111/bjd.19025. View

4.
Damiani G, Bragazzi N, Garbarino S, Chattu V, Shapiro C, Pacifico A . Psoriatic and psoriatic arthritis patients with and without jet-lag: does it matter for disease severity scores? Insights and implications from a pilot, prospective study. Chronobiol Int. 2019; 36(12):1733-1740. PMC: 6832868. DOI: 10.1080/07420528.2019.1678629. View

5.
Papadavid E, Dalamaga M, Vlami K, Koumaki D, Gyftopoulos S, Christodoulatos G . Psoriasis is associated with risk of obstructive sleep apnea independently from metabolic parameters and other comorbidities: a large hospital-based case-control study. Sleep Breath. 2017; 21(4):949-958. DOI: 10.1007/s11325-017-1507-4. View